Treatment with medications affecting dopaminergic and serotonergic mechanisms: Effects on fluency and anxiety in persons who stutter

Allsopp, 1984, Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice, Current Medical Research Opinions, 9, 64, 10.1185/03007998409109561 Alm, 2004, Stuttering and the basal ganglia circuits: A critical review of possible relations, Journal of Communication Disorders, 37, 325, 10.1016/j.jcomdis.2004.03.001 Andrews, 1977, Haloperidol and the treatment of stuttering, Journal of Fluency Disorders, 2, 217, 10.1016/0094-730X(77)90025-0 Bloch, 1997, Pimozide-induced depression in men who stutter, Journal of Clinical Psychiatry, 58, 433, 10.4088/JCP.v58n1004 Bloch, 1995, Severe psychiatric symptoms associated with paroxetine withdrawal, Lancet, 346, 57, 10.1016/S0140-6736(95)92691-7 Bloodstein, 1950, A rating scale study of conditions under which stuttering is reduced or absent, Journal of Speech and Hearing Disorders, 15, 29, 10.1044/jshd.1501.29 Brady, 1991, The pharmacology of stuttering: A critical review, American Journal of Psychiatry, 148, 1309, 10.1176/ajp.148.10.1309 Brady, 1989, A trial of verapamil in the treatment of stuttering in adults, Biological Psychiatry, 25, 630, 10.1016/0006-3223(89)90224-2 Braun, 1997, Altered patterns of cerebral activity during speech and language production in developmental stuttering, Brain, 120, 761, 10.1093/brain/120.5.761 Brumfitt, 1988, A double-blind study of verapamil in the treatment of stuttering, British Journal of Disorders of Communication, 23, 35, 10.3109/13682828809019875 Burns, 1978, The acute effect of haloperidol and apomorphine on the severity of stuttering, Biological Psychiatry, 13, 255 Clutter, 1984, Stuttering: The six blind men revisited, Journal of Fluency Disorders, 9, 89, 10.1016/0094-730X(84)90010-X Corso, 1992, Development of a questionnaire for detecting potential adverse drug reactions, Annals of Pharmacotherapy, 26, 890, 10.1177/106002809202600704 Costa, 1995, Sertraline in stuttering, Journal of Clinical Psychopharmacology, 15, 443, 10.1097/00004714-199512000-00011 Craig, 1990, An investigation into the relationship between anxiety and stuttering, Journal of Speech and Hearing Disorders, 55, 290, 10.1044/jshd.5502.290 De Nil, 2000, A positron emission tomography study of silent and oral single word reading in stuttering and nonstuttering adults, Journal of Speech, Language and Hearing, 43, 1038, 10.1044/jslhr.4304.1038 DiCarlo, 1959, An exploratory investigation of the effect of meprobamate on stuttering behavior, Journal of Nervous and Mental Disorders, 128, 558, 10.1097/00005053-195912860-00007 Doongaji, 1981, Pimozide versus chlordiazepoxide in anxiety neurosis, Acta Psychiatrica Belgica, 81, 416 Doongaji, 1976, A double blind study of pimozide versus chlordiazepoxide in anxiety neuroses, Acta Psychiatrica Belgica, 76, 632 Dunbar, 1992, The anti-anxiety and anti-agitation effects of paroxetine in depressed patients, International Clinical Psychopharmacology, 6, 81, 10.1097/00004850-199206004-00014 Fish, 1965, The effect of treatment with d-amphetamine and a tranquilizing agent, trifluoperazine, California Medicine, 103, 337 Fox, 1996, A PET study of the neural systems of stuttering, Nature, 382, 158, 10.1038/382158a0 Goodman, 1990, Specificity of serotonin reuptake inhibitors in the treament of obsessive-compulsive disorder, Archives of General Psychiatry, 47, 577, 10.1001/archpsyc.1990.01810180077011 Gordon, 1995, A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering, Journal of Clinical Psychiatry, 56, 238 Holliday, 1959, Effect of meprobamate on stuttering, Northwest Medicine, 59, 837 Kent, 1963, The use of tranquilizers in the treatment of stuttering, Journal of Speech and Hearing Disorders, 28, 288, 10.1044/jshd.2803.288 Kent, 1959, Use of meprobamate as an adjunct to stuttering therapy, Journal of Speech and Hearing Disorders, 24, 64, 10.1044/jshd.2401.64 Kenway, 1973, A double-blind comparison of pimozide and haloperidol in the treatment of recurrent anxiety states, The British Journal of Clinical Practice, 27, 67 Kymissis, 1990, Antistuttering medication?, Journal of the American Academy of Child and Adolescent Psychiatry, 29, 840, 10.1097/00004583-199009000-00037 Lavid, 1999, Management of child and adolescent stuttering with olanzapine: Three case reports, Annals of Clinical Psychiatry, 11, 233, 10.3109/10401239909147075 Leith, 1983, The stutterer's reaction to the telephone as a speaking situation, Journal of Fluency Disorders, 8, 233, 10.1016/0094-730X(83)90037-2 Lovett, 1988, Stuttering and anxiety, British Journal of Psychiatry, 153, 844, 10.1192/bjp.153.6.844 Ludlow, 1993, Research evaluating the use of neuropharmacological agents for treating stuttering: Possibilities and problems, Journal of Fluency Disorders, 18, 169, 10.1016/0094-730X(93)90005-O Maguire, 1999, Stuttering: Neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity, Comparative Psychiatry, 40, 308, 10.1016/S0010-440X(99)90132-3 Maguire, 2000, Risperidone for the treatment of stuttering, Journal of Clinical Psychopharmacology, 20, 479, 10.1097/00004714-200008000-00013 Maguire, 2004, Olanzapine in the treatment of developmental stuttering: A double-blind, placebo-controlled trial, Annals of Clinical Psychiatry, 16, 63, 10.1080/10401230490452834 Maguire, 1997, PET scan evidence of parallel cerebral systems related to treatment effects: Effects of risperidone in the treatment of stuttering, 379 Maguire, 2004, Alleviating stuttering with pharmacological interventions, Expert Opinion on Pharmacotherapy, 5, 1565, 10.1517/14656566.5.7.1565 Martin, 1975, The use of haloperidol in the management of stuttering: A case study, Journal of Fluency Disorders, 1, 13, 10.1016/0094-730X(74)90011-4 Maxwell, 1958, Meprobamate in the treatment of stuttering, British Medical Journal, 5075, 873, 10.1136/bmj.1.5075.873 McTavish, 1990, Clomipramine: An overview of its pharmacological properties and a review of its therapeutic use in obsessive-compulsive disorder and panic disorder, Drugs, 39, 136, 10.2165/00003495-199039010-00010 Miller, 1992, The relationship between communication attitude, anxiety, and depression in stutterers and nonstutterers, Journal of Speech and Hearing Research, 35, 789, 10.1044/jshr.3504.789 Murray, 1977, Haloperidol in the treatment of stuttering, British Journal of Psychiatry, 130, 370, 10.1192/bjp.130.4.370 Murray, 1997, Paroxetine for treatment of obsessive–compulsive disorder and comorbid stuttering, American Journal of Psychiatry, 154, 1037, 10.1176/ajp.154.7.1037a Prins, 1980, Principal and differential effects of haloperidol and placebo treatments upon speech disfluencies in stutterers, Journal of Speech and Hearing Research, 23, 614, 10.1044/jshr.2303.614 Quinn, 1973, Haloperidol in the treatment of stutterers, British Journal of Psychiatry, 123, 247, 10.1192/bjp.123.2.247 Rantala, 1976, Haloperidol (Serenase) in the treatment of stuttering, Folia Phoniatrica, 28, 354, 10.1159/000264059 Riley, 1980 Rosenberger, 1976, The effect of haloperidol on stuttering, American Journal of Psychiatry, 133, 331, 10.1176/ajp.133.3.331 Rustin, 1981, Controlled trial of speech therapy versus oxprenolol for stammering, British Medical Journal, 283, 517, 10.1136/bmj.283.6290.517 Schwartz, 1988, Subgrouping young stutterers: Preliminary behavioral observations, Journal of Speech and Hearing Research, 31, 62, 10.1044/jshr.3101.62 Spehr, 1981, The impact of long-time low-dosage haloperidol therapy on anxiety proneness, Agressologie, 22, 33 Spielberger, 1970 Stager, 1997, A double-blind trial of pimozide and paroxetine for stuttering, 371 Stager, 1995, Fluency changes in persons who stutter following a double-blind trial of clomipramine and desipramine, Journal of Speech and Hearing Research, 38, 516, 10.1044/jshr.3803.516 Swift, 1975, Haloperidol as a treatment for adult stuttering, Comprehensive Psychiatry, 16, 61, 10.1016/0010-440X(75)90022-X Thoren, 1980, Clomipramine treatment of obsessive–compulsive disorder: A controlled clinical trial, Archives of General Psychiatry, 37, 1289, 10.1001/archpsyc.1980.01780240087010 Watson, 1988, A comparison of stutterers’ and nonstutterers’ affective, cognitive, and behavioral self-reports, Journal of Speech and Hearing Research, 31, 377, 10.1044/jshr.3103.377 Wells, 1971, Controlled trial of the treatment of 36 stutterers, British Journal of Psychiatry, 119, 603, 10.1192/bjp.119.553.603 Wingerson, 1992, Clomipramine treatment for generalized anxiety disorder, Journal of Clinical Psychopharmacology, 12, 214, 10.1097/00004714-199206000-00013 Wu, 1997, Increased dopamine activity associated with stuttering, NeuroReport, 8, 767, 10.1097/00001756-199702100-00037 Zachariah, 1980, Verapamil in the management of stammering, The Antiseptic (India), 77, 87